Related Experiment Video

Updated: Jan 20, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K

Discovery of New Inhibitors of Transforming Growth Factor-Beta Type 1 Receptor by Utilizing Docking and

Jun-Hao Jiang1, Ping Deng2

  • 1College of Pharmacy, Chongqing Medical University, No. 1 Yixueyuan Road, Yuzhong District, Chongqing 400016, China.

International Journal of Molecular Sciences
|August 24, 2019
PubMed

Insights

Researchers identified novel pyrrolotriazine compounds that effectively inhibit the transforming growth factor-beta (TGF-β) signaling pathway, offering new therapeutic strategies for cancer treatment.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Computational Drug Design

Background:

  • Transforming growth factor-beta (TGF-β) signaling is implicated in pathological fibrosis and cancer progression.
  • Inhibiting the TGF-β pathway presents a promising therapeutic strategy for various cancers.

Purpose of the Study:

  • To design and screen novel pyrrolotriazine-based compounds targeting the TGF-β type 1 receptor (TβR1).
  • To analyze structure-activity relationships and identify potent inhibitors for cancer therapy.

Main Methods:

  • Molecular docking simulations were employed to analyze binding modes of 47 pyrrolotriazine derivatives with TβR1.
  • Structure-activity relationships were evaluated, leading to the design of 29,254 new virtual compounds.
  • Lipinski's rule of five and molecular docking guided the selection of five potential drug candidates (CQMU1901-1905).

Main Results:

  • The study identified five novel compounds (CQMU1901-1905) with potential TβR1 inhibitory activity.
  • CQMU1905, a combination of 5-fluorouracil, 6-mercaptopurine, and 5-azacytosine, showed particular promise.
  • The identified compounds demonstrated superior interaction with target proteins compared to existing agents.

Conclusions:

  • The novel pyrrolotriazine compounds (CQMU1901-1905) show significant potential for inhibiting the TGF-β pathway in cancer.
  • CQMU1905 represents an attractive candidate due to its composition and potential efficacy.
  • These compounds warrant further investigation for their therapeutic applications in oncology.
Keywords:
TGF-betaTGF-βTβR1discovery studiodockinginhibitorsstructure-activity relationship

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.1K

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Relationship Growth01:27

Relationship Growth

Interpersonal relationships progress through stages, beginning with awareness and moving toward mutuality, where emotional connections deepen. While many relationships remain at moderate levels of mutuality, deeper connections form through self-disclosure, trust, and interdependence.Self-DisclosureSelf-disclosure involves revealing personal information, starting with surface-level details and gradually progressing to more intimate content. As trust grows, individuals feel more comfortable...
208
Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.4K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K
Accessory Structures of the Skin: Hair Growth and Types01:20

Accessory Structures of the Skin: Hair Growth and Types

Hair growth begins with the production of keratinocytes by the basal cells of the hair bulb. As new cells are deposited at the hair bulb, the hair shaft is pushed through the follicle toward the surface. Keratinization is completed as the cells are pushed to the skin surface to form the shaft of hair that is externally visible. The external hair is completely dead and composed entirely of keratin. Hair can be cut or shaven without damaging the hair structure because the cut is superficial. Most...
2.3K